Seer Inc Quick Ratio (SEER) starting from the third quarter 2026 to third quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Seer Inc   (NASDAQ: SEER)

Seer Inc 's Quick Ratio

SEER's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the third quarter 2026, Quick Ratio deteriorated to 2.95 below Seer Inc 's average Quick Ratio.

Within Laboratory Analytical Instruments industry Seer Inc booked the highest Quick Ratio than Seer Inc in the third quarter 2026. While Quick Ratio total ranking has improved so far during the Q3 2026 to 82, from total ranking in the second quarter 2026 at 193.

Explain Quick Ratio?
How much Cash & cash equivalents SEER´s has?
What are SEER´s Current Liabilities?




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/SEER/financial-strength
https://api.csimarket.com/api/v1/companies/SEER/fundamentals
https://api.csimarket.com/api/v1/companies/SEER/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
SEER Quick Ratio (Sep 30 2026)
Q3
(Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
Y / Y Current Liabilities Change -33.91 %
Y / Y Cash & cash equivalent Change -85.29 %
Quick Ratio MRQ 2.95
SEER's Total Ranking # 82
Seq. Current Liabilities Change -11.76 %
Seq. Cash & cash equivalent Change -94.6 %



Quick Ratio third quarter 2026 Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 0
Healthcare Sector # 10
Overall Market # 82


Quick Ratio Statistics
High Average Low
110.94 22.39 0.05
(Dec 31 2020)   (Dec 31 2015)




Financial Statements
Seer Inc 's Current Liabilities $ 10 Millions Visit SEER's Balance sheet
Seer Inc 's Cash & cash equivalent $ 29 Millions Visit SEER's Balance sheet
Source of SEER's Sales Visit SEER's Sales by Geography


Cumulative Seer Inc 's Quick Ratio

SEER's Quick Ratio for the trailling 12 Months

SEER Quick Ratio

(Sep 30 2026)
12 Months
(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth -14.83 %
Y / Y Cash & cash equivalent TTM Growth 4.49 %
Quick Ratio TTM 19.62
Total Ranking TTM # 3454
Seq. Current Liabilities TTM Growth -9.76 %
Seq. Cash & cash equivalent TTM Growth -15.52 %


On the trailing twelve months basis In spite of the year on year decrease in SEER's Current Liabilities to $9.94 millions, cumulative Quick Ratio to 19.62 above the company average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Laboratory Analytical Instruments industry 20 other companies have achieved higher Quick Ratio than Seer Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2026 from 2428 to 3454.

Explain Quick Ratio?
How much Cash & cash equivalents SEER´s has?
What are SEER´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Laboratory Analytical Instruments Industry # 21
Healthcare Sector # 852
Within the Market # 3454


trailing twelve months Quick Ratio Statistics
High Average Low
50.75 8.85 0.13
(Sep 30 2021)   (Mar 31 2016)




Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Laboratory Analytical Instruments Industry Quick RatioSep 30 2026 MRQ Cash & cash equivalentSep 30 2026 MRQ Current Liabilities
Alamar Biosciences Inc   6.77 $ 226.585  Millions$ 33.482  Millions
Standard Biotools Inc   5.24 $ 267.487  Millions$ 51.021  Millions
10x Genomics Inc   4.10 $ 575.725  Millions$ 140.370  Millions
Pacific Biosciences Of California Inc   3.01 $ 200.217  Millions$ 66.593  Millions
Seer Inc   2.95 $ 29.316  Millions$ 9.942  Millions
Cytek Biosciences Inc   2.58 $ 255.899  Millions$ 99.179  Millions
Quanterix Corporation  1.51 $ 77.359  Millions$ 51.130  Millions
Nautilus Biotechnology Inc   1.07 $ 10.467  Millions$ 9.758  Millions
Precipio inc   0.90 $ 3.576  Millions$ 3.985  Millions
Bio rad Laboratories Inc   0.86 $ 837.100  Millions$ 969.100  Millions
Bionano Genomics Inc   0.66 $ 8.168  Millions$ 12.307  Millions
Revvity Inc  0.63 $ 592.799  Millions$ 936.977  Millions

Date modified: 2026-11-11T13:59:37+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.